Curebase
Curebase is a San Francisco-based clinical trials technology company (founded 2017) that provides a modern, AI-native eClinical platform for sponsors, CROs, biotechs, MedTech companies, and research sites. The platform unifies the full trial lifecycle in one system: ePRO/eCOA (electronic patient-reported and clinical outcome assessments), eConsent (digital informed consent), EDC (electronic data capture), patient recruitment and screening, participant engagement and retention tooling, and site management. Curebase also ships Sitebase, a free eClinical suite for research sites, and Hope, a conversational AI voice agent. It supports decentralized and hybrid trial models natively. Curebase is a private, venture-backed company (Series B led by Industry Ventures; investors include GGV Capital, Acrew, Gilead, and others). It is SOC 2 Type II certified and GDPR compliant. Curebase does not publish a public developer API or API documentation; integration is handled through enterprise engagements.
Curebase is profiled on the APIs.io network. Tagged areas include Company, Health, Clinical Trials, eClinical, and Life Sciences.
Curebase’s developer surface includes engineering blog, support, signup flow, and 9 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API